(Q37849630)

English

The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate

scientific article published on June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

chelation therapy

0 references

1 reference

based on heuristic

inferred from title

David P. Steensma

1

object named as

David P Steensma

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Current hematologic malignancy reports

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

136-144

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Myelodysplasia paranoia: iron as the new radon

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Iron chelation therapy in myelodysplastic syndrome - Cui bono?

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Controversies surrounding iron chelation therapy for MDS.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Myelodysplastic syndromes--coping with ineffective hematopoiesis

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Anemia in the elderly: how should we define it, when does it matter, and what can be done?

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Iron: The fifth horseman of the apocalypse?

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

The granulocyte-macrophage colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Iron chelation therapy in MDS: what have we learnt recently?

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1007%2FS11899-011-0084-Z

21 January 2018

Natural history of idiopathic refractory sideroblastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue iron overload and mechanisms of iron-catalyzed oxidative injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of iron chelation therapy for patients with myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deferoxamine treatment as a risk factor for zygomycete infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement on iron overload in myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21373838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11899-011-0084-Z

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37849630&oldid=2201011651"